Modulation of Metal Homeostasis for Cancer Therapy

This review summarizes the strategies employed to modulate the homeostasis of iron, zinc, copper, manganese, and calcium for cancer therapy. Small molecule-based chelators, ionophores, metal complexes, and metal-based nanomaterials are developed to restore the normal balance of metals in cancer cells or exploit the dysregulation for the inhibition of cell proliferation, induction of cell death, and regulation of tumor microenvironment.

Abstract

Metal ions such as iron, zinc, copper, manganese, and calcium are essential for normal cellular processes, including DNA synthesis, enzyme activity, cellular signaling, and oxidative stress regulation. When the balance of metal homeostasis is disrupted, it can lead to various pathological conditions, including cancer. Thus, understanding the role of metal homeostasis in cancer has led to the development of anti-tumor strategies that specifically target the metal imbalance. Up to now, diverse small molecule-based chelators, ionophores, metal complexes, and metal-based nanomaterials have been developed to restore the normal balance of metals or exploit the dysregulation for therapeutic purposes. They hold great promise in inhibiting tumor growth, preventing metastasis, and enhancing the effectiveness of existing cancer therapies. In this review, we aim to provide a comprehensive summary of the strategies employed to modulate the homeostasis of iron, zinc, copper, manganese, and calcium for cancer therapy. Their modulation mechanisms for metal homeostasis are succinctly described, and their recent applications in the field of cancer therapy are discussed. At the end, the limitations of these approaches are addressed, and potential avenues for future developments are explored.

Zum Volltext